Healthcare Services Group financials
$20.90+0.58%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Quarter | Q2 '26 Jun 30 | Q1 '26 Mar 31 | Q4 '25 Dec 31 | Q3 '25 Sep 30 | Q2 '25 Jun 30 | Q1 '25 Mar 31 | Q4 '24 Dec 31 | Q3 '24 Sep 30 | Q2 '24 Jun 30 | Q1 '24 Mar 31 | Q4 '23 Dec 31 | Q3 '23 Sep 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $470.8M | $462.8M | $466.7M | $464.3M | $458.5M | $447.7M | $437.8M | $428.1M | $426.3M | $423.4M | $423.8M | $411.4M |
| Gross profit | $74.8M | $75.8M | $72.1M | $96.4M | $3.0M | $68.0M | $58.6M | $63.4M | $41.5M | $64.5M | $74.7M | $34.5M |
| Gross margin | 15.9% | 16.4% | 15.4% | 20.8% | 0.6% | 15.2% | 13.4% | 14.8% | 9.7% | 15.2% | 17.6% | 8.4% |
| Operating income | $22.2M | $33.8M | $25.9M | $45.9M | -$46.2M | $23.0M | $13.8M | $16.5M | -$2.9M | $17.6M | $28.5M | -$4.6M |
| Net income | $22.7M | $25.7M | $31.2M | $43.0M | -$32.4M | $17.7M | $11.9M | $14.0M | -$1.8M | $15.3M | $23.5M | -$5.0M |
| Net margin | 4.8% | 5.5% | 6.7% | 9.3% | −7.1% | 4.0% | 2.7% | 3.3% | −0.4% | 3.6% | 5.5% | −1.2% |
| Diluted EPS | $0.32 | $0.37 | $0.43 | $0.59 | $-0.44 | $0.23 | $0.16 | $0.19 | $-0.02 | $0.21 | $0.32 | $-0.07 |
| EBITDA | $25.7M | $37.7M | $29.7M | $50.0M | -$41.1M | $27.0M | $17.9M | $20.5M | $1.1M | $21.6M | $28.5M | -$809.0K |
| Operating cash flow | $21.9M | $43.7M | $17.4M | $71.3M | $28.8M | $27.5M | $36.2M | $4.3M | $16.3M | -$26.0M | $49.4M | $2.9M |
| Free cash flow | $20.2M | $42.3M | $16.0M | $70.0M | $27.4M | $25.8M | $34.8M | $2.9M | $15.0M | -$28.2M | $48.0M | $1.1M |
| Diluted shares | 69.9M | 71.0M | 72.0M | 73.0M | 73.2M | 74.0M | 74.1M | 73.9M | 73.9M | 74.1M | 73.9M | 74.4M |
Balance sheet
| Period end | Jun 30 | Mar 31 | Dec 31 | Sep 30 | Jun 30 | Mar 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $123.4M | $136.2M | $125.2M | $124.4M | $82.8M | $64.3M |
| Short-term investments | $41.3M | $42.4M | $42.8M | $53.1M | $51.7M | $0.00 |
| Total debt | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total assets | $820.9M | $814.8M | $794.3M | $804.3M | $802.2M | $823.0M |
| Total liabilities | $302.0M | $301.1M | $284.0M | $308.3M | $325.2M | $308.8M |
| Shareholders' equity | $518.8M | $513.8M | $510.2M | $496.0M | $477.0M | $514.2M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology